Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The intestinal epithelial mucosa is the innermost layer of the gastrointestinal tract, serving as a critical interface between the external environment of the lumen and the internal systemic circulation (StatPearls, 2023). It is composed of a single layer of specialized epithelial cells—including enterocytes, goblet cells, and enteroendocrine cells—supported by the lamina propria and the muscularis mucosae (NIH, 2022). Its primary biological functions include the selective absorption of nutrients and water while maintaining a robust physical and immunological barrier against pathogens and toxins through tight junction proteins and mucus production. Dysfunction of this mucosal barrier or dysregulation of the associated mucosal immune system is a central feature in the pathogenesis of Inflammatory Bowel Disease (IBD), Celiac disease, and various enteric infections (Nature Reviews Gastroenterology & Hepatology, 2021). While many therapeutic agents are designed to act upon specific molecular targets within this tissue, such as TNF-alpha or integrins, the mucosa itself is considered a complex anatomical site of action rather than a discrete molecular target.
Drugs targeting the intestinal mucosa typically work by inhibiting pro-inflammatory cytokines (e.g., TNF-alpha), blocking the trafficking of leukocytes into the mucosal tissue (e.g., alpha-4 beta-7 integrin antagonism), or providing local anti-inflammatory effects to promote mucosal healing and restore barrier integrity (PubMed, 2022).
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Intestinal epithelial mucosa.